Patents by Inventor Hui-Kang LIU

Hui-Kang LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10272124
    Abstract: Disclosed is a use of Helminthostachys zeylanica, ugonins or compounds of formula (I) for the treatment or prevention of metabolic diseases comprising at least one selected from metabolic syndrome, excessive lipid accumulation, obesity, overweight, fatty liver, hepatic steatosis, hepatitis, cirrhosis, liver cancer, dyslipidemia, hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, hypercholesterolemia, cardiovascular disease, hyperglycemia, hyperinsulinemia, diabetes mellitus type 2, insulin resistance, insulin disorder, impaired glucose tolerance and a combination thereof.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: April 30, 2019
    Assignee: NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE
    Inventors: Cheng Huang, Keng-Chang Tsai, Yu-Ling Huang, Ming-Jaw Don, Hsiu-Chen Huang, Wang-Chuan Chen, Hui-Kang Liu
  • Publication number: 20170348367
    Abstract: Disclosed is a use of Helminthostachys zeylanica, ugonins or compounds of formula (I) for the treatment or prevention of metabolic diseases comprising at least one selected from metabolic syndrome, excessive lipid accumulation, obesity, overweight, fatty liver, hepatic steatosis, hepatitis, cirrhosis, liver cancer, dyslipidemia, hyperlipidemia, hypertriglyceridemia, hyperlipoproteinemia, hypercholesterolemia, cardiovascular disease, hyperglycemia, hyperinsulinemia, diabetes mellitus type 2, insulin resistance, insulin disorder, impaired glucose tolerance and a combination thereof.
    Type: Application
    Filed: April 12, 2017
    Publication date: December 7, 2017
    Inventors: Cheng HUANG, Keng-Chang TSAI, Yu-Ling HUANG, Ming-Jaw DON, Hsiu-Chen HUANG, Wang-Chuan CHEN, Hui-Kang LIU